Back to Results
First PageMeta Content
Medicinal chemistry / Clinical research / Pharmaceutical industry / Bioavailability / ADME / Absorption / Drug discovery / Abbreviated New Drug Application / Ursodiol / Pharmaceutical sciences / Pharmacology / Pharmacokinetics


1 BARRIERS TO ORAL BIOAVAILABILITY—AN OVERVIEW Ming Hu Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX AL
Add to Reading List

Document Date: 2013-08-25 16:11:16

Open Document

File Size: 603,62 KB

Share Result on Facebook

City

Stockton / /

Company

John Wiley & Sons Inc. / INTRODUCTION CO / /

Continent

Europe / /

Country

United States / /

Event

FDA Phase / /

Facility

University of Houston / /

IndustryTerm

prevention of prostate cancer / pharmaceutical technologies / finished product / food intake / drug delivery technologies / manufacturing / pharmaceutical / food effects / passive and carrier-mediated uptake transporters / pharmaceutical economists / food / /

MedicalCondition

HIV / chronic administration / prostate cancer / /

MedicalTreatment

gene therapy / drug delivery system / dietary supplements / polypharmacy / /

Organization

Congress / University of Houston / Houston / OVERVIEW Ming Hu Department of Pharmacological and Pharmaceutical Sciences / Food and Drug Administration / TX AL / FDA / References RI Department of Pharmaceutics and Medicinal Chemistry / University of the Pacific / /

Person

Ming Hu / Xiaoling Li / /

Position

nurse / physician / forward / /

Product

Deliv Rev 46 / Caco-2 / to / bioavailability / CYP3A4 / /

Technology

gene therapy / genomics / pharmacokinetics / Drug metabolism / proteomics / drug delivery / drug discovery / drug delivery technologies / drug delivery system / nutraceuticals / human genome / drug development / /

SocialTag